|
市場調査レポート
商品コード
1671893
ウィルソン病治療の世界市場：治療タイプ別、投与経路別、年齢層別、流通チャネル別、地域別Wilson's Disease Treatment Market, By Type of Treatment, By Route of Administration, By Age Group, By Distribution Channel, By Geography |
||||||
カスタマイズ可能
|
|||||||
| ウィルソン病治療の世界市場：治療タイプ別、投与経路別、年齢層別、流通チャネル別、地域別 |
|
出版日: 2025年02月26日
発行: Coherent Market Insights
ページ情報: 英文 185 Pages
納期: 2～3営業日
|
- 全表示
- 概要
- 目次
世界のウィルソン病治療の市場規模は、2025年には6億3,080万米ドルと推定され、2032年には9億9,320万米ドルに達し、2025年～2032年のCAGRは6.7%で成長すると予測されます。
| レポート対象範囲 | レポート詳細 | ||
|---|---|---|---|
| 基準年 | 2024年 | 2025年の市場規模 | 6億3,080万米ドル |
| 実績データ | 2020年～2024年 | 予測期間 | 2025年～2032年 |
| 予測期間：2025年～2032年 CAGR： | 6.70% | 2032年の価値予測 | 9億9,320万米ドル |
ウィルソン病は、肝臓や脳のような他の重要な臓器に銅が蓄積する稀な遺伝子疾患です。胆汁や尿を通して銅を放出する体の能力に影響を与えます。ウィルソン病を未治療のままにしておくと、深刻な医学的問題を引き起こし、死に至ることもあります。しかし、適切な診断と治療により、患者の余命は大幅に改善されます。この疾患に対する認識が世界的に高まるにつれ、より多くの患者が診断され、効果的な治療を受けています。このことは、予測期間中、世界のウィルソン病治療市場の着実な成長を促進すると予想されます。
市場力学：
世界のウィルソン病治療市場は、疾患認知度の向上と新たな診断により、緩やかな成長が見込まれます。また、新規治療薬の開発も機会を提供すると期待されています。しかし、銅キレート剤は希少疾病治療薬であるため、コストが高く、市場拡大の妨げになる可能性があります。加えて、発展途上国では病気に対する意識が低いという課題もあります。とはいえ、任意団体や政府の支援プログラムによるイニシアチブは、特に低・中所得国において、購入しやすさの問題を解決し、診断を改善するのに役立つと思われます。
本調査の主な特徴
本レポートでは、世界のウィルソン病治療市場を詳細に分析し、2024年を基準年とした予測期間（2025～2032年）の市場規模および複合年間成長率（CAGR%）を掲載しています。
また、さまざまなセグメントにわたる潜在的な収益機会を明らかにし、この市場の魅力的な投資提案マトリクスについて解説しています。
また、市場促進要因、抑制要因、機会、新製品の上市や承認、市場動向、地域別の展望、主要企業が採用する競争戦略などに関する重要な考察も提供しています。
世界のウィルソン病治療市場における主要企業プロファイルを、企業ハイライト、製品ポートフォリオ、主要ハイライト、業績、戦略などのパラメータに基づいて掲載しています。
本調査の対象となる主要企業には、Valeant Pharmaceuticals International、Merck &Co、Tsumura &Co、VHB Life Science Inc.、Teva Pharmaceuticals USA Inc.、Wilson's Therapeutics AB、Noble Pharma Co.Ltd.、Kadmon Holdings Inc.、Zydus Cadila、Mylan N.V.、Hikma Pharmaceuticals、Sandoz（ノバルティス部門）、Aurobindo Pharma、Amgen Inc.、Pfizer Inc.などがあります。
本レポートから得られる洞察により、マーケティング担当者や各企業の経営陣は、将来の製品上市、タイプアップ、市場拡大、マーケティング戦術に関して、十分な情報に基づいた意思決定を行うことができます。
世界のウィルソン病治療市場レポートは、投資家、サプライヤー、製品メーカー、流通業者、新規参入者、財務アナリストなど、この業界の様々な利害関係者を対象としています。
利害関係者は、世界のウィルソン病治療市場の分析に使用される様々な戦略マトリックスを通じて、意思決定が容易になります。
目次
第1章 調査の目的と前提条件
- 調査目的
- 前提条件
- 略語
第2章 市場の展望
- レポートの説明
- 市場の定義と範囲
- エグゼクティブサマリー
第3章 市場力学、規制、動向分析
- 市場力学
- 影響分析
- 主な発展
- 規制シナリオ
- 製品の発売/承認
- PEST分析
- ポーターの分析
- 合併と買収のシナリオ
- 業界動向
第4章 世界のウィルソン病治療市場：治療タイプ別（2020年～2032年）
- 薬物治療
- 肝臓移植
- 食事管理
第5章 世界のウィルソン病治療市場：投与経路別（2020年～2032年）
- 経口
- 非経口
- その他
第6章 世界のウィルソン病治療市場：年齢層別（2020年～2032年）
- 子供
- 大人
- 高齢者
第7章 世界のウィルソン病治療市場：流通チャネル別（2020年～2032年）
- 院内薬局
- 小売薬局
- オンライン薬局
第8章 世界のウィルソン病治療市場：地域別（2020年～2032年）
- 北米
- ラテンアメリカ
- 欧州
- アジア太平洋
- 中東
- アフリカ
第9章 競合情勢
- Valeant Pharmaceuticals International
- Merck & Co
- Tsumura & Co
- VHB Life Science Inc.
- Teva Pharmaceuticals USA Inc.
- Wilson's Therapeutics AB
- Noble Pharma Co. Ltd
- Kadmon Holdings Inc.
- Zydus Cadila
- Mylan N.V.
- Hikma Pharmaceuticals
- Sandoz（a Novartis division）
- Aurobindo Pharma
- Amgen Inc.
- Pfizer Inc.
第10章 アナリストの推奨事項
- 運命の輪
- アナリストの見解
- Coherent Opportunity Map（COM）
第11章 参考文献と調査手法
- 参考文献
- 調査手法
- 出版社について
Wilson's Disease Treatment Market is estimated to be valued at US$ 630.8 Mn in 2025 and is expected to reach US$ 993.2 Mn by 2032, growing at a compound annual growth rate (CAGR) of 6.7% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | US$ 630.8 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 6.70% | 2032 Value Projection: | US$ 993.2 Mn |
Wilson's disease is a rare genetic disorder that causes copper to accumulate in the liver and other vital organs like the brain. It affects the ability of the body to release copper through bile and urine. Untreated Wilson's disease can cause serious medical problems and may become fatal. However, with proper diagnosis and treatment, life expectancy of patients can be improved significantly. As awareness about this condition is rising globally, more patients are being diagnosed and treated effectively. This is expected to drive steady growth in the global Wilson's disease treatment market during the forecast period.
Market Dynamics:
The global Wilson's disease treatment market is anticipated to witness moderate growth attributed to rising disease awareness and new diagnosis. Development of novel drugs for treatment is also expected to provide opportunities. However, high costs associated with copper-chelating agents, being orphan drugs, can hamper market expansion to some extent. Additionally, lack of disease awareness in developing nations poses a challenge. Nonetheless, initiatives by voluntary organizations as well as government support programs can help address affordability issues and improve diagnosis especially in low-and middle-income countries.
Key Features of the Study:
This report provides in-depth analysis of the global Wilson's disease treatment market, and provides market size (USD Mn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the global Wilson's disease treatment market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
Key companies covered as a part of this study include Valeant Pharmaceuticals International, Merck & Co, Tsumura & Co, VHB Life Science Inc., Teva Pharmaceuticals USA Inc., Wilson's Therapeutics AB, Noble Pharma Co. Ltd, Kadmon Holdings Inc., Zydus Cadila, Mylan N.V., Hikma Pharmaceuticals, Sandoz (a Novartis division), Aurobindo Pharma, Amgen Inc., and Pfizer Inc.
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
The global Wilson's disease treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Wilson's disease treatment market
Market Segmentation
- By Type of Treatment Insights (Revenue, USD Mn, 2020 - 2032)
- Pharmacological Treatment
- Chelation Therapy
- Zinc Therapy
- Liver Transplantation
- Dietary Management
- By Route of Administration Insights (Revenue, USD Mn, 2020 - 2032)
- Oral
- Parenteral
- Others
- By Age Group Insights (Revenue, USD Mn, 2020 - 2032)
- Pediatric
- Adult
- Geriatric
- By Distribution Channel Insights (Revenue, USD Mn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- Regional Insights (Revenue, USD Mn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Valeant Pharmaceuticals International
- Merck & Co
- Tsumura & Co
- VHB Life Science Inc.
- Teva Pharmaceuticals USA Inc.
- Wilson's Therapeutics AB
- Noble Pharma Co. Ltd
- Kadmon Holdings Inc.
- Zydus Cadila
- Mylan N.V.
- Hikma Pharmaceuticals
- Sandoz (a Novartis division)
- Aurobindo Pharma
- Amgen Inc.
- Pfizer Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Wilson's Disease Treatment Market, By Type of Treatment
- Global Wilson's Disease Treatment Market, By Route of Administration
- Global Wilson's Disease Treatment Market, By Age Group
- Global Wilson's Disease Treatment Market, By Distribution Channel
- Global Wilson's Disease Treatment Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Wilson's Disease Treatment Market, By Type of Treatment, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pharmacological Treatment
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Liver Transplantation
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Dietary Management
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
5. Global Wilson's Disease Treatment Market, By Route of Administration, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Parenteral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
6. Global Wilson's Disease Treatment Market, By Age Group, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
7. Global Wilson's Disease Treatment Market, By Distribution Channel, 2020-2032, (USD Mn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Mn)
8. Global Wilson's Disease Treatment Market, By Region, 2020 - 2032, Value (USD Mn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Mn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Mn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Mn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type of Treatment, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Age Group , 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Mn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Mn)
- South Africa
- North Africa
- Central Africa
9. Competitive Landscape
- Valeant Pharmaceuticals International
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Tsumura & Co
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- VHB Life Science Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceuticals USA Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Wilson's Therapeutics AB
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Noble Pharma Co. Ltd
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kadmon Holdings Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Zydus Cadila
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Hikma Pharmaceuticals
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sandoz (a Novartis division)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Aurobindo Pharma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amgen Inc.
- Pfizer Inc.
10. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
11. References and Research Methodology
- References
- Research Methodology
- About us
